ATE490323T1 - Adiponektin-rezeptor und dafür kodierendes gen - Google Patents

Adiponektin-rezeptor und dafür kodierendes gen

Info

Publication number
ATE490323T1
ATE490323T1 AT03733398T AT03733398T ATE490323T1 AT E490323 T1 ATE490323 T1 AT E490323T1 AT 03733398 T AT03733398 T AT 03733398T AT 03733398 T AT03733398 T AT 03733398T AT E490323 T1 ATE490323 T1 AT E490323T1
Authority
AT
Austria
Prior art keywords
protein
adiponectin
binding ability
gene coding
adiponectin receptor
Prior art date
Application number
AT03733398T
Other languages
English (en)
Inventor
Takashi Kadowaki
Toshimasa Yamauchi
Ryozo Nagai
Jyunji Kamon
Original Assignee
Toudai Tlo Ltd
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toudai Tlo Ltd, Nissan Chemical Ind Ltd filed Critical Toudai Tlo Ltd
Application granted granted Critical
Publication of ATE490323T1 publication Critical patent/ATE490323T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
  • Credit Cards Or The Like (AREA)
  • Manipulator (AREA)
AT03733398T 2002-12-29 2003-06-12 Adiponektin-rezeptor und dafür kodierendes gen ATE490323T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002383738 2002-12-29
PCT/JP2003/007515 WO2004061108A1 (ja) 2002-12-29 2003-06-12 アディポネクチン受容体及びそれをコードする遺伝子

Publications (1)

Publication Number Publication Date
ATE490323T1 true ATE490323T1 (de) 2010-12-15

Family

ID=32708748

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03733398T ATE490323T1 (de) 2002-12-29 2003-06-12 Adiponektin-rezeptor und dafür kodierendes gen

Country Status (7)

Country Link
US (4) US20040241802A1 (de)
EP (2) EP1589106B1 (de)
JP (1) JP3955885B2 (de)
AT (1) ATE490323T1 (de)
AU (1) AU2003242352A1 (de)
DE (1) DE60335216D1 (de)
WO (1) WO2004061108A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1589106B1 (de) 2002-12-29 2010-12-01 Toudai Tlo, Ltd. Adiponektin-rezeptor und dafür kodierendes gen
ATE554393T1 (de) * 2003-09-27 2012-05-15 Siemens Healthcare Diagnostics Diagnostika und therapeutika für mit adiponectin receptor 2 (adipor2) assoziierten erkrankungen
EP1685846B1 (de) * 2003-11-04 2014-11-26 Daiichi Sankyo Company, Limited Antitumorales mittel
WO2005084697A1 (ja) * 2004-03-04 2005-09-15 Takashi Kadowaki アディポネクチン受容体発現制御剤
US7741080B2 (en) 2004-03-31 2010-06-22 Nissan Chemical Industries, Ltd. Adiponectin expression-inducing agents and uses thereof
US7399742B2 (en) * 2004-07-23 2008-07-15 Depuy Spine, Inc. Anti-osteolytic therapy involving adiponectin
US20060069024A1 (en) * 2004-09-27 2006-03-30 Purdue Research Foundation Plant PR-5 proteins as mammalian therapeutic agents
US7749956B2 (en) 2005-01-07 2010-07-06 Xencor, Inc. Method of treatment using adiponectin variants
US7592423B2 (en) * 2005-01-07 2009-09-22 Xencor, Inc. Globular adiponectin variants
EP1833845A2 (de) * 2005-01-07 2007-09-19 Xencor Adiponectinvarianten
US7678886B2 (en) * 2005-01-07 2010-03-16 Xencor, Inc. Pharmaceutical compositions of adiponectin variants and methods of storage
US20070054359A1 (en) * 2005-07-11 2007-03-08 Jonathan Zalevsky Rational Chemical Modification of Adiponectin Variants
US8093017B2 (en) 2005-12-07 2012-01-10 Siemens Heathcare Diagnostics Inc. Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
WO2007125324A1 (en) * 2006-04-26 2007-11-08 Astrazeneca Ab Method of screening for an antagonist of adiponectin receptor 2 and uses thereof
JP2008109925A (ja) * 2006-10-04 2008-05-15 Japan Science & Technology Agency アディポネクチン受容体遺伝子欠損非ヒト動物及びその用途
US8809001B2 (en) * 2007-09-24 2014-08-19 University Of Florida Research Foundation, Inc. High throughput assays for inhibitors and activators of PAQR receptors
CN101932728B (zh) 2007-11-30 2013-06-19 西门子医疗保健诊断公司 脂连蛋白受体片段和使用方法
EP3444611A1 (de) 2009-04-23 2019-02-20 Siemens Healthcare Diagnostics Inc. Monomere und dimere formen von adiponectin-rezeptor-fragmenten sowie und verfahren zur verwendung davon
US20110104666A1 (en) * 2009-11-02 2011-05-05 Toshiya Matsubara Insulin resistance marker
US20130274185A1 (en) * 2010-03-16 2013-10-17 The University Of Tokyo Pharmaceutical for Pseudo-Exercise Therapy
JP5048100B2 (ja) * 2010-04-28 2012-10-17 シャープ株式会社 アディポネクチンに対する結合性を有するペプチド、ならびに該ペプチドを用いた分析方法および分析装置
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
WO2018223119A1 (en) * 2017-06-02 2018-12-06 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Engineered cells, and methods of using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0814159B1 (de) 1990-08-29 2005-07-27 GenPharm International, Inc. Transgene Mäuse fähig zur Produktion heterologer Antikörper
WO1993002227A1 (en) 1991-07-15 1993-02-04 Eco-Tec Limited Process and apparatus for treating fluoride containing acid solutions
EP0652950B1 (de) 1992-07-24 2007-12-19 Amgen Fremont Inc. Bildung von xenogenen antikörpern
ATE390933T1 (de) 1995-04-27 2008-04-15 Amgen Fremont Inc Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
AU2466895A (en) 1995-04-28 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
US20040067490A1 (en) * 2001-09-07 2004-04-08 Mei Zhong Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2002191363A (ja) * 1999-07-29 2002-07-09 Herikkusu Kenkyusho:Kk 全長ｃＤＮＡ合成用プライマー、およびその用途
EP1074617A3 (de) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
CA2382015A1 (en) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Membrane associated proteins
EP1572987A4 (de) * 2000-02-03 2005-11-30 Nuvelo Inc Neuartige nukleinsäure und polypeptide
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1589106B1 (de) 2002-12-29 2010-12-01 Toudai Tlo, Ltd. Adiponektin-rezeptor und dafür kodierendes gen
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
US7435808B2 (en) * 2003-06-25 2008-10-14 Bristol-Myers Squibb Company Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2

Also Published As

Publication number Publication date
DE60335216D1 (de) 2011-01-13
AU2003242352A1 (en) 2004-07-29
EP2141235A1 (de) 2010-01-06
EP1589106B1 (de) 2010-12-01
EP2141235B1 (de) 2014-06-11
US20070054314A1 (en) 2007-03-08
EP1589106A4 (de) 2006-06-07
WO2004061108A1 (ja) 2004-07-22
US7977459B2 (en) 2011-07-12
JP3955885B2 (ja) 2007-08-08
US20040241802A1 (en) 2004-12-02
US20100062541A1 (en) 2010-03-11
AU2003242352A8 (en) 2004-07-29
US7501490B2 (en) 2009-03-10
US8252584B2 (en) 2012-08-28
EP1589106A1 (de) 2005-10-26
US20120027760A1 (en) 2012-02-02
JPWO2004061108A1 (ja) 2006-05-11

Similar Documents

Publication Publication Date Title
ATE490323T1 (de) Adiponektin-rezeptor und dafür kodierendes gen
DE60332320D1 (de) Neues screening-verfahren
CY1108998T1 (el) Πρωτεϊνες που δεσμευονται με οστεοπροτεγερινη και υποδοχεις
ATE283365T1 (de) Il-1 rezeptor fusionsproteine verwendet als antagoniste und verfahren zu deren verwendung und herstellung
HK1080511A1 (en) Il-1 receptor based antagonists and methods of making and using
EP1541686A4 (de) Antikörperkonstruktion unter verwendung einer mrl/lpr-maus
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
DE69941701D1 (de) Mutanten von flt3-l und ihre verwendungen
DE60236921D1 (de) Verfahren und zusammensetzungen zur verwendung von mhc-klasse ii-invariante-kette-polypeptid als rezeptor für makrophagenwanderung-hemmfaktor
WO2000031262A3 (en) Human neurotensin subtype 2 receptor
DE602004030899D1 (de) Neues screening-verfahren
EP1584925A4 (de) Neues screening-verfahren
ATE367438T1 (de) Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
WO2003082320A1 (fr) Nouveau procede de criblage
ATE447586T1 (de) Fprl1-liganden und deren verwendung
EP1617216A4 (de) Neues screening-verfahren
WO2006005473A3 (en) Rat trace amine associated receptors
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
DE60236643D1 (de) Opiatrezeptoren
DE60128026D1 (de) Verfahren zur Beurteilung der Widerstandsfähigkeit gegen den Ausbruch von Leukämie bei Rindern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties